Qingqing Cai, PhD¹, Panpan Liu, MD, PhD^1*, Yi Xia, MD, PhD^1*, Jun Cai^1*, Huiqiang Huang, MD, PhD², Zhiming Li^1*, Hui Zhou^3*, Yajun Li, MD, PhD^3*, Hanyu Wang, MD, PhD^4*, Ying Huang, MD, PhD^5*, Gao Yan, PhD¹ and Xueyi Pan, MD, PhD^6*

¹Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
²Department of Medical Oncology, Sun Yat-Sen Univ. Cancer Ctr., Guangzhou, Guangdong, China
³Department of Lymphoma and Hematology, Hunan Cancer Hospital, Xiangya School of Medicine, the Affiliated Cancer Hospital, Changsha, China
⁴Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Gaungzhou, China
⁵Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁶Department of Hematology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

Olivier Tournilhac, MD, PhD^1*, Solene Lecolant, PharmD^2*, Maya Hacini, MD^3*, Krimo Bouabdallah, MD^4*, Sebastien Bailly^5*, Kamel Laribi, MD^6*, Thibaut Belmondo, MD^7*, Marie Maerevoet^8*, Loic Ysebaert, MD, PhD^9*, Stéphanie Guidez, MD^10*, Steven Le Gouill, MD, PhD¹¹, Christophe Bonnet, MD, PhD^12*, Marc Andre, MD^13*, Jehan Dupuis, MD^14*, Catherine Thieblemont, MD, PhD¹⁵, Emmanuel Bachy, MD, PhD^16*, Nicolas Daguindau, MD^17*, Franck Morschhauser, MD, PhD^18,19*, Sabine Tricot, MD^20*, Pierre Feugier, MD^21*, Anne Banos, MD^22*, Thierry Lamy^23*, Adrien Chauchet, MD^24*, Emmanuel Gyan, MD, PhD²⁵, Guillaume Cartron, MD, PhD^26*, Hassan Farhat, MD^27*, Vincent Camus, MD^28*, Bernard Drenou^29*, Hacene Zerazhi^30*, David Sibon, MD, PhD^31*, Emmanuelle Nicolas-Virelizier, MD^32*, Caroline Delette, MD^33*, Sylvia Snauwaert, MD^34*, Nicole Straetmans, MD, PhD³⁵, Richard Delarue, MD³⁶, Marie Parrens, MD, PhD^37*, Samuel Griolet^38*, Philippe Gaulard, MD, PhD^39*, Marie-Helene Delfau-Larue, MD PhD^40*, Laurence De Leval, MD⁴¹ and Gandhi Laurent Damaj, MD, PhD, Prof^42*

¹Service d'Hématologie Clinique et Thérapie Cellulaire, CHU, Université Clermont Auvergne EA7453 Chelter CIC-1405, Clermont-Ferrand, FRA
²Department of Biological Hematology and Immunology, Laboratory of Immunology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Creteil, France
³Hematologie, Centre Hospitalier Metropole Savoie, Chambery, FRA
⁴Hematology and Cellular Therapy Department, CHU Bordeaux, Pessac, France
⁵Hématologie et Thérapie Cellulaire, CHU de Clermont-Ferrand, Clermont-Ferrand, France
⁶Hématologie clinique, CH Le Mans, Le Mans, France
⁷Department of Biological Hematology and Immunology; Laboratory of Immunology;, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Créteil, France
⁸Hematology, Institut Jules Bordet, ULB, Brussels, Belgium
⁹IUCT Oncopole, Toulouse, France
¹⁰Service Hématologie et Thérapie cellulaire, CIC INSERM 1402, CHU POITIERS, Poitiers, France
¹¹Institut Curie Comprehensive Cancer Center, Paris, France
¹²Clinical Hematology, CHU University of Liège, Liège, Belgium
¹³Department of Hematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
¹⁴Lymphoid Malignancies Department, Henri Mondor University Hospital, Créteil, France
¹⁵Hemato-oncology Department, Université de Paris Cité/Saint-Louis University Hospital/AP-HP, Paris, France
¹⁶Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
¹⁷Hematology Department, CH Annecy Genevois, Annecy, France
¹⁸CHU Lille, Service des Maladies du Sang, F-59000, Lille, France
¹⁹Department of Clinical Hematology, Centre Hospitalier Regional Universitaire (CHRU) de Lille and Unite Groupe de Recherche sur les Formes Injetables et les Technologies Associees (GRITA), Universite de Lille 2, Lille, France
²⁰Service d'Hématologie Clinique, CH de Valenciennes, Valenciennes, France
²¹Department of Hematology, Henri Poincaré University, CHU NANCY BRABOIS, Vandoeuvre Les Nancy, France
²²Service d'Hematologie, Centre Hospitalier De Bayonne, Bayonne, FRA
²³CHU de Rennes, Service d’Hématologie Clinique, Rennes, France
²⁴Hematology, CHU de Besancon, Besancon, FRA
²⁵Service D'Hematologie et Therapie Cellulaire, CHU de Tours, Tours Cedex, France
²⁶Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
²⁷Department of Hematology, Hôpital André Mignot, Centre Hospitalier de Versailles, Le Chesnay, France
²⁸Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France
²⁹Service d'Hématologie, Groupe Hospitalier de la Région Mulhouse Sud Alsace (GHRMSA), Mulhouse, France
³⁰Hématologie, CH Avignon, Avignon, France
³¹Faculty of Medicine and Health, Campus Henri Mondor, Paris-Est Creteil University, Creteil, France
³²Hematology, Centre Leon Berard, Lyon, France
³³Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Amiens, France
³⁴AZ Sint-Jan, Brugge, Belgium
³⁵Department of Hematology, Cliniques Universitaires Saint-Luc,, Woluwe Saint Lambert, BEL
³⁶Hematology Department / Hemophilia Center, Necker University Hospital, AP-HP, Paris, France
³⁷Department of Pathology, University of Bordeaux, Bordeaux, France
³⁸Centre Hospitalier Lyon Sud, Lymphoma Academic Research Organisation (LYSARC), Lyon, France
³⁹Department of Pathology, Henri Mondor Hospital, APHP, Paris Est-Créteil (UPEC) University Faculty, INSERM UMR-S 955, Créteil, France
⁴⁰Biological Hematology and immunology Department, APHP, CHU Henri Mondor, Creteil, France
⁴¹Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
⁴²Department of Hematology, Hematology Institute University Hospital School of Medicine, Caen, France

Philipp Berning^1*, Maud Ngoya^2*, Norbert Schmitz, MD^1*, Hervé Finel^2*, Ariane Boumendil, PhD^2*, Won-Seog Kim, MD, PhD^3*, Fengrong Wang^4*, Xiao-jun Huang⁴, Olivier Hermine, MD, PhD⁵, Laure Philippe, MD^5*, Lucile Couronne^5*, Arnaud Jaccard^6*, Daihong Liu, MD⁷, Depei Wu⁸, Hans Christian Reinhardt, MD⁹, Yves Chalandon, MD¹⁰, Eva Maria Wagner, MD¹¹, Mi Kwon, MD, PhD^12*, Xi Zhang, M.D., Ph.D.^13*, Ben Carpenter, MD^14*, Ibrahim Yakoub-Agha, MD, PhD¹⁵, Gerald Wulf, MD^16*, Javier López Jiménez, MD, PhD^17*, Jaime Sanz, MD^18*, Hélène Labussière-Wallet^19*, Avichai Shimoni, MD^20*, Peter Dreger, MD²¹, Anna Sureda²² and Bertram Glass^23*

¹Department of Medicine A, University Hospital Münster, Münster, Germany
²EBMT Lymphoma Working Party Paris Office, Paris, France
³Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁴Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁵Department of Hematology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
⁶Department of Hematology, CHU Limoges, Limoges, France
⁷Department of Hematology, Chinese PLA General Hospital, Beijing, China
⁸Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
⁹Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany
¹⁰Department of Hematology, Geneva University Hospital, Geneva, Switzerland
¹¹Department of Haematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany
¹²Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
¹³Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
¹⁴Royal Free and University College Medical School, London, United Kingdom
¹⁵CHU de Lille LIRIC, INSERM U995, Université de Lille, Lille, France
¹⁶Department of Hematology and Oncology, Georg-August-University of Göttingen, Göttingen, Germany
¹⁷Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
¹⁸Avinguda Fernando Abril Martorell, Hospital Universitario La Fe, Valencia, Valencia, Spain
¹⁹Service Hematologie, Centre Hospitalier Lyon Sud, Pavillon Marcel Bérard -Bat 1G, Lyon, France
²⁰Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
²¹Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany
²²Hematology Department, Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
²³Clinic for Hematology, Oncology, Tumorimmunology and Palliative Care, Helios Clinic Berlin-Buch, Berlin, Germany

Bradley M. Haverkos, MD, MS, MPH¹, Jasmine Zain, MD², Manali K. Kamdar, MD¹, Alexander Neuwelt, MD^3*, Eduardo Davila, PhD^4*, Xander Bradeen^1*, Steven M. Bair, MD¹, Jagar Jasem, MD^1*, Emily Berens^5*, Clayton Smith, MD^6*, Diana Abbott, PhD^7* and Pierluigi Porcu, MD⁸

¹Division of Hematology, University of Colorado, Aurora, CO
²City of Hope Comprehensive Cancer Center, Duarte, CA
³Virginia Commonwealth University, Richmond, VA
⁴Division of Oncology, University of Colorado, Aurora, CO
⁵Oncology Clinical Research Support Team, University of Colorado, Aurora, CO
⁶Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
⁷Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Denver, CO
⁸Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA

Jehan Dupuis, MD^1*, Kunihiro Tsukasaki, MD, PhD², Emmanuel Bachy, MD, PhD^3*, Franck Morschhauser, MD, PhD^4*, Guillaume Cartron, MD, PhD^5*, Noriko Fukuhara, MD, PhD⁶, Nicolas Daguindau, MD^7*, René-Olivier Casasnovas, MD, PhD^8*, Sylvia Snauwaert, MD^9*, Rémy Gressin, MD^10*, Christopher P. Fox^11*, Francesco Annibale d'Amore, MD, DMSc¹², Philipp B. Staber, MD, PhD¹³, Argyrios Gkasiamis, MD¹⁴, Mitsufumi Nishio, MD, PhD¹⁵, Luc-Matthieu Fornecker, MD, PhD^16*, Marie-Helene Delfau^17*, Nouhoum Sako, PhD^18*, Sebastien Mule, MD, PhD^19,20*, Laurence De Leval, MD²¹, Philippe Gaulard, MD, PhD^22,23* and Francois Lemonnier^24*

¹Lymphoid Maligancies, Henri Mondor Hospital, Créteil, France
²Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan
³Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
⁴Hematology Department, Lille University Hospital, Lille, France
⁵Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
⁶Department of Hematology, Tohoku University School of Medicine, Sendai, Japan
⁷Hematology Department, CH Annecy Genevois, Annecy, France
⁸Hématologie Clinique, CHU Dijon Bourgogne, Dijon, France
⁹AZ Sint-Jan, Brugge, Belgium
¹⁰Department of Hematology, University, Grenoble, France
¹¹Department of Hematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
¹²Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
¹³Medical University Vienna, Vienna, Austria
¹⁴Bristol Myers Squibb, Boudry, Switzerland
¹⁵Bristok Myers Squibb, tokyo, Japan
¹⁶Institut De CancéRologie Strasbourg Europe, Strasbourg, France
¹⁷Department of Immunology, University Hospital, Creteil, France
¹⁸Institut Mondor de recherche biomédicale, Hôpital Henri Mondor, APHP, Créteil, France
¹⁹Radiology and Medical Imaging, Henri Mondor Hospital, APHP, Créteil, France
²⁰Paris Est-Créteil University, Créteil, France
²¹Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
²²INSERMU955 équipe 9, Institut Mondor de Recherche Biomédicale, Créteil, France
²³Département de Pathologie, Hôpital Henri Mondor & Université Paris Est Créteil, Creteil, France
²⁴Unité Hémopathie Lymphoïde, Hôpital Henri Mondor & Université Paris Est Créteil, Créteil, France

Owhofasa O. Agbedia, MD, MPH¹, Rishab Prakash, BS^2*, Jie Xu, MD^3*, Melody R. Becnel, MD², Ranjit Nair, MD², Raphael E Steiner, MD², Lei Feng, MS^4*, Hun Ju Lee, MD², Paolo Strati, MD², Sairah Ahmed, MD², Simrit Parmar, MD, MSCI², Yago Nieto, MD⁵, Chitra Hosing, MD⁵, Jason Westin, MD², Loretta J. Nastoupil, MD⁶, Ann Vo^2*, Felipe Samaniego, MD², Nathan H. Fowler, MD², Neeraj Saini, MD⁵, Issa F. Khouri, MD⁵, Jin S. Im, MD, PhD⁷, Luis Fayad, MD², Preetesh Jain, MBBS, MD, DM, PhD², Michael L. Wang, MD², Roberto N. Miranda, MD^3*, Francisco Vega, MD, PhD³, Jeffrey Medeiros, MD, PhD^3*, Yasuhiro Oki⁸, Christopher R. Flowers, MD², Sattva S. Neelapu, MD⁹ and Swaminathan P. Iyer, MD²

¹Division Of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁷Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas,, Houston, TX
⁸Genentech, Inc., South San Francisco, CA
⁹Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX